Localized 1H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis

Journal of Neurology

Volumn 249, Issue 7, 2002, Pages 902-910

  Sarchielli, P ^a   Presciutti, O ^b   Tarducci, R ^b   Gobbi, G ^b   Alberti, A ^a   Pelliccioli, G P ^b   Chiarini, P ^b   Gallai, V ^a  

^a POLICLINICO MONTELUCE   (Italy)

^b Perugia General Hospital   (Italy)

Author keywords

Absolute quantification; Brain metabolites; Gray matter; Multiple sclerosis; Proton magnetic resonance spectroscopy

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN NERVE CELL; BRAIN REGION; BRAIN WATER; CELL LOSS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ASPARTIC ACID; ATROPHY; CREATINE; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OCCIPITAL LOBE; PARIETAL LOBE; RECURRENCE; WATER;

EID: 0036310111     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0758-5     Document Type: Article

References (54)

1. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease
2. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques
3. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
4. An early-onset case of multiple sclerosis with thalamic lesions on MRI
5. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis
6. MRI T2 shortening ('black T2') in multiple sclerosis: Frequency, location, and clinical correlation
7. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS
8. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS
9. Cerebral metabolism in a case of multiple sclerosis with acute mental disorder
10. Multiple sclerosis in children: Cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo
11. Quantification of metabolites in human brain by proton magnetic resonance spectroscopy: Methodologies, limitations, and achievements
12. MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing
13. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss
14. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
15. High resolution proton NMR spectroscopy of multiple sclerosis lesions
16. 1H MRS of the human brain addressed by one and the same data-analysis protocol
17. Reversible decreases of N-acetylaspartate in the brain of patients with relapsing-remitting multiple sclerosis
18. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water
19. Axonal damage in acute multiple sclerosis lesions
20. Imaging axonal damage of normal-appearing white matter in multiple sclerosis
21. MR proton spectroscopy in multiple sclerosis
22. Brain creatine kinases and phosphocreatine: An update
23. 1H spectroscopic imaging
24. Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain
25. Cortical lesions in multiple sclerosis
26. Magnetic resonance spectroscopy of multiple sclerosis: In-vivo detection of myelin breakdown products
27. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations
28. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
29. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis
30. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis
31. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy
32. Magnetic resonance imaging and spectroscopy in multiple sclerosis
33. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis
34. Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions
35. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study
36. 1H spectroscopic imaging at 4.1 T
37. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
38. Short echo time proton MR spectroscopic imaging
39. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS
40. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter
41. Proton MRS of gadolinium-enhancing MS plaques
42. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis
43. Cortical and subcortical T2 shortening in multiple sclerosis
44. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients
45. Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis
46. Volume T1-weighted gradient echo MRI in multiple sclerosis patients
47. Clinical significance of reduced cerebral metabolism in multiple sclerosis: A combined PET and MRI study
48. In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis
49. Axonal transection in the lesions of multiple sclerosis
50. 1H magnetic resonance spectroscopy
51. Proton magnetic resonance spectroscopy in multiple sclerosis
52. Extensive proliferation of peripheral type myelin in necrotic spinal cord lesions of multiple sclerosis